Clinical Outcomes of Impella Microaxial Devices Used to Salvage Cardiogenic Shock as a Bridge to Durable Circulatory Support or Cardiac Transplantation

被引:25
|
作者
Cheng, Richard [1 ]
Tank, Rikin [2 ]
Ramzy, Danny [3 ]
Azarbal, Babak [1 ]
Chung, Joshua [3 ]
Esmailian, Fardad [3 ]
Kobashigawa, Jon A. [1 ]
Moriguchi, Jaime D. [1 ]
Arabia, Francisco A. [3 ]
机构
[1] Cedars Sinai Heart Inst, Div Cardiol, 127 S San Vicente Blvd,Suite A3308, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA
[3] Cedars Sinai Heart Inst, Div Cardiothorac Surg, Los Angeles, CA USA
关键词
Impella; severe cardiogenic shock; percutaneous temporary circulatory support; mechanical circulatory support; bridge to decision and transplantation; EXTRACORPOREAL MEMBRANE-OXYGENATION; HEART-TRANSPLANTATION; ARTERY; METAANALYSIS; REMOVAL; ARREST;
D O I
10.1097/MAT.0000000000000877
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Temporary mechanical circulatory support (MCS) can be a bridge to decision for patients in severe cardiogenic shock who may be eligible for durable support or transplantation. Outcomes with Impella microaxial devices for salvage of severe shock in the end-stage heart failure population are not well described. Patients who underwent Impella placement as a bridge to decision, durable MCS, or transplantation were included. Eighty Impella devices (2.5 [1.3%], CP [53.8%], and 5.0 [45.0%]) were placed in 64 patients. Implant age was 56.2 +/- 12.5 years. Mean duration of assisted support was 13.2 +/- 15.1 days, and median duration per device was 7 days (interquartile range: 3-14). A total of 48.4% were in Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS 1) shock at implant, 51.6% in profile 2. Recent cardiopulmonary resuscitation (CPR) (26.7%), ventilator use (67.2%), and extracorporeal membrane oxygenation (ECMO) use (26.7%) were frequent. Forty four of sixty four (68.8%) survived to next therapy: durable MCS (40.9%), heart transplant (OHT) (36.4%), and recovery (22.7%). Overall 30 and 60 day survival were 67.2% and 65.6%, respectively. Thirty and 60 day survival conditional on having survived to next therapy were 94.1% and 91.2%, respectively. Survivors were less likely to be on ventilators (p = 0.049) or continuous renal replacement therapy (p < 0.001) but were otherwise not different from nonsurvivors by age, sex, INTERMACS profile, CPR, prevalence of ischemic cardiomyopathy, among other characteristics. Sixteen patients were directly bridged to heart transplantation, and all were alive at long-term follow-up. Impella devices can be used to salvage patients in severe heart failure as a bridge to decision, durable MCS, or transplantation. Baseline demographics are not predictive of survival. Their use for this indication is increasing and further investigations are warranted.
引用
收藏
页码:642 / 648
页数:7
相关论文
共 50 条
  • [1] Clinical and Laboratory Outcomes of Impella Microaxillary Pumps When Used in Patients With Severe Cardiogenic Shock as a Bridge to Durable Devices or Cardiac Transplantation
    Cheng, Richard
    Tank, Rikin
    Ramzy, Danny
    Azarbal, Babak
    Ebinger, Joseph
    Esmailian, Fardad
    Kobashigawa, Jon
    Moriguchi, Jaime
    Arabia, Francisco
    CIRCULATION, 2017, 136
  • [2] Clinical Outcomes of Impella Microaxillary Pumps When Used in Patients with Cardiogenic Shock Bridged Successfully to Durable Mechanical Circulatory Support and Cardiac Transplantation
    Cheng, R.
    Ramzy, D.
    Azarbal, B.
    Esmailian, F.
    Geft, D.
    Chang, D. H.
    Passano, E.
    Czer, L.
    Kobashigawa, J. A.
    Moriguchi, J.
    Arabia, F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S139 - S139
  • [3] Comparative outcomes in cardiogenic shock patients managed with Impella microaxial pump or extracorporeal life support
    Lamarche, Yoan
    Cheung, Anson
    Ignaszewski, Andrew
    Higgins, Jennifer
    Kaan, Annemarie
    Griesdale, Donald E. G.
    Moss, Robert
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2011, 142 (01): : 60 - 65
  • [4] Impact of Impella Support on Clinical Outcomes in Patients with Postcardiotomy Cardiogenic Shock
    Sugimura, Yukiharu
    Immohr, Moritz Benjamin
    Mehdiani, Arash
    Boeken, Udo
    Aubin, Hug
    Lichtenberg, Artur
    Akhyari, Payam
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 30 (01)
  • [5] Utilization and Outcomes of Temporary Mechanical Circulatory Support Devices in Cardiogenic Shock
    Enezate, Tariq
    Eniezat, Mohammad
    Thomas, Joseph
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 (04): : 505 - 510
  • [6] Percutaneous Impella Device for Mechanical Circulatory Support in Children with Cardiogenic Shock: Long Term Outcomes
    Tume, S. C.
    Anders, M.
    Dreyer, W.
    Adachi, I.
    Justino, H.
    Qureshi, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S220 - S220
  • [7] Ischemic cardiogenic shock and short-term mechanical circulatory support as bridge to transplantation
    Renedo, Maria F.
    Chao, Chen
    Absi, Daniel O.
    Bertolotti, Alejandro M.
    Vigliano, Carlos A.
    Favaloro, Roberto R.
    MEDICINA-BUENOS AIRES, 2021, 81 (05) : 761 - 766
  • [8] Axillary Temporary Mechanical Circulatory Support to Bridge Cardiogenic Shock Patients to Heart Transplantation
    Aleman, R. A.
    Napoli, F. A.
    Baran, D. A.
    Velez, M. A.
    Estep, J. A.
    Sheffield, C. A.
    Navia, J. L.
    Brozzi, N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S281 - S281
  • [9] Comparing Hemodynamic Profiles and Outcomes in Cardiogenic Shock Requiring VA-ECMO or Impella for Circulatory Support
    Esposito, Michele
    Kuchibhotla, Sudeep
    Zisa, David
    O'Kelly, Ryan
    Annamalai, Shiva
    Ghuloom, Adel
    Lussier, Leslie
    Breton, Catalina
    Pedicini, Robert
    Mullin, Andrew
    Kimmelstiel, Carey
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B45 - B46
  • [10] Clinical Outcomes Among Patients Requiring Acute Mechanical Circulatory Support for Cardiogenic Shock Supported by Impella or VA-ECMO
    Morine, Kevin
    Esposito, Michele
    Annamalai, Shiva
    Pedicini, Robert
    Jorde, Lena
    Gobeil, Kyle
    Hernandez-Montfort, Jamie
    Kapur, Navin
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (04) : S3 - S3